Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:37670241

Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells.

Seiichi Okabe · Akihiko Gotoh

BMC cancer · 2023 doi:10.1186/s12885-023-11304-4

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:37670241
kind
science-record
content_hash
sha256:77e414b3dc7c816a96fb471bf36266387193c4beb5e89477a3e3b35f3b7d4b17
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T19:02:27Z
updated_at
2026-11-01T21:31:28Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells.
doi
10.1186/s12885-023-11304-4
pmid
37670241
authors array · 2 items
[0]
Seiichi Okabe
[1]
Akihiko Gotoh
journal
BMC cancer
year
2023
abstract
BACKGROUND: Abelson (ABL) tyrosine kinase inhibitors (TKIs) are effective against chronic myeloid leukemia (CML); however, many patients develop resistance during ABL TKI therapy. Vitamin K2 (VK2) is a crucial fat-soluble vitamin used to activate hepatic coagulation factors and treat osteoporosis. Although VK2 has demonstrated impressive anticancer activity in various cancer cell lines, it is not known whether VK2 enhances the effects of asciminib, which specifically targets the ABL myristoyl pocket (STAMP) inhibitor. METHOD: In this work, we investigated whether VK2 contributed to the development of CML cell lines. We also investigated the efficacy of asciminib and VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 BCR-ABL, and T315I point mutant Ba/F3 (Ba/F3 T315I) cells. RESULTS: Based on data from the Gene Expression Omnibus (GEO) database, gamma-glutamyl carboxylase (GGCX) and vitamin K epoxide reductase complex subunit 1 (VKORC1) were elevated in imatinib-resistant patients (GSE130404). UBIA Prenyltransferase Domain Containing 1 (UBIAD1) was decreased, and K562 PR cells were resistant to ponatinib. In contrast, asciminib inhibited CML cells and ponatinib resistance in a dose-dependent manner. CML cells were suppressed by VK2. Caspase 3/7 activity was also elevated, as was cellular cytotoxicity. Asciminib plus VK2 therapy induced a significantly higher level of cytotoxicity than use of each drug alone. Asciminib and VK2 therapy altered the mitochondrial membrane potential. CONCLUSIONS: Asciminib and VK2 are suggested as a novel treatment for ABL-TKI-resistant cells since they increase treatment efficacy. Additionally, this treatment option has intriguing clinical relevance for patients who are resistant to ABL TKIs.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
A t test was used to determine whether differences in drug treatment groups were statistically significant compared with the control group.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37670241
locator
sections[16] "Statistical analysis" paragraph 2
quote
A t test was used to determine whether differences in drug treatment groups were statistically significant compared with the control group.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37670241
locator
sections[30] "Data Availability" paragraph 2
quote
The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:37670241
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE130404
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE130404
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:37670241
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s12885-023-11304-4
sha256
sha256:db6b66fc94f14eee7f955baeee44c9967795eb4b801b8bbf449d4f96f9dd51a1
bytes
40136
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s12885-023-11304-4
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC10478393
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE130404
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130404
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE130404
version
null
note
The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.
access_statement_kind
data_availability_statement
sample_accessions array · 96 items
[0]
GSM3737693
[1]
GSM3737694
[2]
GSM3737695
[3]
GSM3737696
[4]
GSM3737697
[5]
GSM3737698
[6]
GSM3737699
[7]
GSM3737700
[8]
GSM3737701
[9]
GSM3737702
[10]
GSM3737703
[11]
GSM3737704
[12]
GSM3737705
[13]
GSM3737706
[14]
GSM3737707
[15]
GSM3737708
[16]
GSM3737709
[17]
GSM3737710
[18]
GSM3737711
[19]
GSM3737712
[20]
GSM3737713
[21]
GSM3737714
[22]
GSM3737715
[23]
GSM3737716
[24]
GSM3737717
[25]
GSM3737718
[26]
GSM3737719
[27]
GSM3737720
[28]
GSM3737721
[29]
GSM3737722
[30]
GSM3737723
[31]
GSM3737724
[32]
GSM3737725
[33]
GSM3737726
[34]
GSM3737727
[35]
GSM3737728
[36]
GSM3737729
[37]
GSM3737730
[38]
GSM3737731
[39]
GSM3737732
[40]
GSM3737733
[41]
GSM3737734
[42]
GSM3737735
[43]
GSM3737736
[44]
GSM3737737
[45]
GSM3737738
[46]
GSM3737739
[47]
GSM3737740
[48]
GSM3737741
[49]
GSM3737742
[50]
GSM3737743
[51]
GSM3737744
[52]
GSM3737745
[53]
GSM3737746
[54]
GSM3737747
[55]
GSM3737748
[56]
GSM3737749
[57]
GSM3737750
[58]
GSM3737751
[59]
GSM3737752
[60]
GSM3737753
[61]
GSM3737754
[62]
GSM3737755
[63]
GSM3737756
[64]
GSM3737757
[65]
GSM3737758
[66]
GSM3737759
[67]
GSM3737760
[68]
GSM3737761
[69]
GSM3737762
[70]
GSM3737763
[71]
GSM3737764
[72]
GSM3737765
[73]
GSM3737766
[74]
GSM3737767
[75]
GSM3737768
[76]
GSM3737769
[77]
GSM3737770
[78]
GSM3737771
[79]
GSM3737772
[80]
GSM3737773
[81]
GSM3737774
[82]
GSM3737775
[83]
GSM3737776
[84]
GSM3737777
[85]
GSM3737778
[86]
GSM3737779
[87]
GSM3737780
[88]
GSM3737781
[89]
GSM3737782
[90]
GSM3737783
[91]
GSM3737784
[92]
GSM3737785
[93]
GSM3737786
[94]
GSM3737787
[95]
GSM3737788
sample_count
96
group_sizes
null
group_sizes_basis
null
platform
10558
taxon
Homo sapiens
title
Gene expression signature that predicts early molecular response failure in chronic phase CML patients on frontline imatinib
resolution_checked_at
2026-11-01T19:09:46Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:GSE130404 not downloaded
[1]
asset:data:geo:GSE130404 licence not read
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
t test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
A t test was used to determine whether differences in drug treatment groups were statistically significant compared with the control group.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocking_axis
method
blocked_on
method:not_determinable
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (t test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE130404
resolved_accessions array · 1 item
[0]
GSE130404
statements array · 1 item
[0]
The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.
basis
The paper names GSE130404 in NCBI Gene Expression Omnibus and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:37670241
[1]
data:geo:GSE130404
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE130404
gaps array · 1 item
[0]
method:not_determinable
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T18:52:28Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
12816
completion_tokens
1638
cached_tokens
256
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:37670241
type
paper
label
pmid:37670241
[1] object · 3 fields
id
source:pmid:37670241
type
manuscript
label
PMID 37670241 full text
[2] object · 3 fields
id
data:geo:GSE130404
type
dataset
label
GEO GSE130404
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:37670241
type
paper
label
pmid:37670241
[1] object · 3 fields
id
source:pmid:37670241
type
manuscript
label
PMID 37670241 full text
[2] object · 3 fields
id
data:geo:GSE130404
type
dataset
label
GEO GSE130404
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-37670241
type
extraction
used array · 1 item
[0]
source:pmid:37670241
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE130404
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE130404
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:37670241
parent_hash
sha256:811a344e7e0e892ff905ea248fb48c4fe263f432d2386409c037ec32c901a097
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:GSE130404 licence not read
[1]
asset:data:geo:GSE130404 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
cell_culture
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
d the efficacy of asciminib and VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 B
[1]
b and VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 BCR-ABL, and T315I point mu
[2]
VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 BCR-ABL, and T315I point mutant B
[3]
ain Containing 1 (UBIAD1) was decreased, and K562 PR cells were resistant to ponatinib. In con
order_basis
paper_text_order:761
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
apoptosis_assay
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.77
evidence array · 1 item
[0]
nt manner. CML cells were suppressed by VK2. Caspase 3/7 activity was also elevated, as was cellu
order_basis
paper_text_order:1335
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:37670241", "kind": "science-record", "revision": 3, "content_hash": "sha256:77e414b3dc7c816a96fb471bf36266387193c4beb5e89477a3e3b35f3b7d4b17", "created_at": "2026-11-01T19:02:27Z", "updated_at": "2026-11-01T21:31:28Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells.", "doi": "10.1186/s12885-023-11304-4", "pmid": "37670241", "authors": ["Seiichi Okabe", "Akihiko Gotoh"], "journal": "BMC cancer", "year": 2023, "abstract": "BACKGROUND: Abelson (ABL) tyrosine kinase inhibitors (TKIs) are effective against chronic myeloid leukemia (CML); however, many patients develop resistance during ABL TKI therapy. Vitamin K2 (VK2) is a crucial fat-soluble vitamin used to activate hepatic coagulation factors and treat osteoporosis. Although VK2 has demonstrated impressive anticancer activity in various cancer cell lines, it is not known whether VK2 enhances the effects of asciminib, which specifically targets the ABL myristoyl pocket (STAMP) inhibitor.\nMETHOD: In this work, we investigated whether VK2 contributed to the development of CML cell lines. We also investigated the efficacy of asciminib and VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 BCR-ABL, and T315I point mutant Ba/F3 (Ba/F3 T315I) cells.\nRESULTS: Based on data from the Gene Expression Omnibus (GEO) database, gamma-glutamyl carboxylase (GGCX) and vitamin K epoxide reductase complex subunit 1 (VKORC1) were elevated in imatinib-resistant patients (GSE130404). UBIA Prenyltransferase Domain Containing 1 (UBIAD1) was decreased, and K562 PR cells were resistant to ponatinib. In contrast, asciminib inhibited CML cells and ponatinib resistance in a dose-dependent manner. CML cells were suppressed by VK2. Caspase 3/7 activity was also elevated, as was cellular cytotoxicity. Asciminib plus VK2 therapy induced a significantly higher level of cytotoxicity than use of each drug alone. Asciminib and VK2 therapy altered the mitochondrial membrane potential.\nCONCLUSIONS: Asciminib and VK2 are suggested as a novel treatment for ABL-TKI-resistant cells since they increase treatment efficacy. Additionally, this treatment option has intriguing clinical relevance for patients who are resistant to ABL TKIs.", "claims": [{"id": "claim-method", "statement": "A t test was used to determine whether differences in drug treatment groups were statistically significant compared with the control group.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:37670241", "locator": "sections[16] \"Statistical analysis\" paragraph 2", "quote": "A t test was used to determine whether differences in drug treatment groups were statistically significant compared with the control group."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:37670241", "locator": "sections[30] \"Data Availability\" paragraph 2", "quote": "The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:37670241"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE130404"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE130404"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:37670241", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s12885-023-11304-4", "sha256": "sha256:db6b66fc94f14eee7f955baeee44c9967795eb4b801b8bbf449d4f96f9dd51a1", "bytes": 40136, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s12885-023-11304-4", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10478393", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE130404", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130404", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE130404", "version": null, "note": "The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM3737693", "GSM3737694", "GSM3737695", "GSM3737696", "GSM3737697", "GSM3737698", "GSM3737699", "GSM3737700", "GSM3737701", "GSM3737702", "GSM3737703", "GSM3737704", "GSM3737705", "GSM3737706", "GSM3737707", "GSM3737708", "GSM3737709", "GSM3737710", "GSM3737711", "GSM3737712", "GSM3737713", "GSM3737714", "GSM3737715", "GSM3737716", "GSM3737717", "GSM3737718", "GSM3737719", "GSM3737720", "GSM3737721", "GSM3737722", "GSM3737723", "GSM3737724", "GSM3737725", "GSM3737726", "GSM3737727", "GSM3737728", "GSM3737729", "GSM3737730", "GSM3737731", "GSM3737732", "GSM3737733", "GSM3737734", "GSM3737735", "GSM3737736", "GSM3737737", "GSM3737738", "GSM3737739", "GSM3737740", "GSM3737741", "GSM3737742", "GSM3737743", "GSM3737744", "GSM3737745", "GSM3737746", "GSM3737747", "GSM3737748", "GSM3737749", "GSM3737750", "GSM3737751", "GSM3737752", "GSM3737753", "GSM3737754", "GSM3737755", "GSM3737756", "GSM3737757", "GSM3737758", "GSM3737759", "GSM3737760", "GSM3737761", "GSM3737762", "GSM3737763", "GSM3737764", "GSM3737765", "GSM3737766", "GSM3737767", "GSM3737768", "GSM3737769", "GSM3737770", "GSM3737771", "GSM3737772", "GSM3737773", "GSM3737774", "GSM3737775", "GSM3737776", "GSM3737777", "GSM3737778", "GSM3737779", "GSM3737780", "GSM3737781", "GSM3737782", "GSM3737783", "GSM3737784", "GSM3737785", "GSM3737786", "GSM3737787", "GSM3737788"], "sample_count": 96, "group_sizes": null, "group_sizes_basis": null, "platform": "10558", "taxon": "Homo sapiens", "title": "Gene expression signature that predicts early molecular response failure in chronic phase CML patients on frontline imatinib", "resolution_checked_at": "2026-11-01T19:09:46Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE130404 not downloaded", "asset:data:geo:GSE130404 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "t test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "A t test was used to determine whether differences in drug treatment groups were statistically significant compared with the control group."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (t test), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE130404"], "resolved_accessions": ["GSE130404"], "statements": ["The datasets generated and/or analyzed during the current study are available in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository with the accession numbers GSE130404."], "basis": "The paper names GSE130404 in NCBI Gene Expression Omnibus and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:37670241", "data:geo:GSE130404"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE130404"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T18:52:28Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 12816, "completion_tokens": 1638, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:37670241", "type": "paper", "label": "pmid:37670241"}, {"id": "source:pmid:37670241", "type": "manuscript", "label": "PMID 37670241 full text"}, {"id": "data:geo:GSE130404", "type": "dataset", "label": "GEO GSE130404"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:37670241", "type": "paper", "label": "pmid:37670241"}, {"id": "source:pmid:37670241", "type": "manuscript", "label": "PMID 37670241 full text"}, {"id": "data:geo:GSE130404", "type": "dataset", "label": "GEO GSE130404"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-37670241", "type": "extraction", "used": ["source:pmid:37670241"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE130404", "type": "accession_resolution", "used": ["data:geo:GSE130404"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:37670241", "parent_hash": "sha256:811a344e7e0e892ff905ea248fb48c4fe263f432d2386409c037ec32c901a097", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:GSE130404 licence not read", "asset:data:geo:GSE130404 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["d the efficacy of asciminib and VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 B", "b and VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 BCR-ABL, and T315I point mu", "VK2 by using K562, ponatinib-resistant K562 (K562 PR), Ba/F3 BCR-ABL, and T315I point mutant B", "ain Containing 1 (UBIAD1) was decreased, and K562 PR cells were resistant to ponatinib. In con"], "order_basis": "paper_text_order:761", "id": "assay:1"}, {"role": "data_generation", "definition_id": "apoptosis_assay", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.77, "evidence": ["nt manner. CML cells were suppressed by VK2. Caspase 3/7 activity was also elevated, as was cellu"], "order_basis": "paper_text_order:1335", "id": "assay:2"}]}